miRNA Assays |
NanoString Platform |
Qiagen Platform |
WaferGen Platform |
A/A |
B/A |
C/A |
D/A |
A/A |
B/A |
C/A |
D/A |
A/A |
B/A |
C/A |
D/A |
HSA-let-7d |
1 |
0.85 |
3.02 |
2.29 |
1.00 |
1.37 |
5.06 |
5.58 |
1.00 |
1.02 |
2.48 |
2.59 |
HSA-let-7g |
1 |
0.99 |
7.18 |
5.78 |
1.00 |
0.78 |
9.34 |
10.75 |
1.00 |
1.13 |
4.11 |
4.49 |
HSA-let-7i |
1 |
1.03 |
4.27 |
2.97 |
1.00 |
0.86 |
4.78 |
5.03 |
1.00 |
1.03 |
3.20 |
3.17 |
HSA-MIR-100 |
1 |
1.05 |
2.89 |
2.57 |
1.00 |
0.85 |
4.30 |
3.61 |
1.00 |
0.96 |
2.74 |
3.17 |
HSA-MIR-10a |
1 |
1.13 |
8.61 |
6.29 |
1.00 |
1.18 |
58.49 |
50.91 |
1.00 |
0.97 |
3.99 |
4.51 |
HSA-MIR-126 |
1 |
0.92 |
4.08 |
3.56 |
1.00 |
0.86 |
4.68 |
3.63 |
1.00 |
0.98 |
4.30 |
4.68 |
HSA-MIR-140 |
1 |
1.13 |
1.96 |
2.63 |
1.00 |
0.94 |
7.38 |
7.82 |
1.00 |
1.18 |
5.85 |
6.59 |
HSA-MIR-151 |
1 |
1.41 |
4.85 |
5.61 |
1.00 |
0.80 |
4.20 |
2.48 |
1.00 |
0.93 |
3.58 |
3.40 |
HSA-MIR-15a |
1 |
0.88 |
7.62 |
6.43 |
1.00 |
0.82 |
7.31 |
9.74 |
1.00 |
0.92 |
8.01 |
7.74 |
HSA-MIR-15b |
1 |
0.87 |
2.61 |
2.46 |
1.00 |
1.17 |
2.84 |
4.02 |
1.00 |
1.07 |
2.47 |
2.78 |
HSA-MIR-16 |
1 |
1.05 |
3.78 |
4.02 |
1.00 |
0.87 |
3.54 |
2.58 |
1.00 |
0.98 |
3.76 |
4.03 |
HSA-MIR-191 |
1 |
1.23 |
3.31 |
2.40 |
1.00 |
0.92 |
4.50 |
3.54 |
1.00 |
1.08 |
3.07 |
3.14 |
HSA-MIR-200c |
1 |
1.10 |
0.01 |
0.01 |
1.00 |
0.62 |
0.00 |
0.00 |
1.00 |
1.00 |
0.00 |
0.00 |
HSA-MIR-205 |
1 |
0.82 |
0.00 |
0.00 |
1.00 |
0.77 |
0.00 |
0.00 |
1.00 |
0.97 |
0.00 |
0.00 |
HSA-MIR-29a |
1 |
1.12 |
3.80 |
3.54 |
1.00 |
0.79 |
4.23 |
4.26 |
1.00 |
1.02 |
2.89 |
3.63 |
HSA-MIR-29b |
1 |
1.09 |
2.28 |
5.12 |
1.00 |
0.93 |
3.93 |
9.65 |
1.00 |
0.79 |
9.07 |
9.39 |
HSA-MIR-29c |
1 |
0.84 |
2.70 |
2.87 |
1.00 |
0.83 |
4.17 |
4.33 |
1.00 |
0.81 |
2.92 |
3.57 |
HSA-MIR-30a |
1 |
0.64 |
4.71 |
5.11 |
1.00 |
0.66 |
4.30 |
4.91 |
1.00 |
0.76 |
5.04 |
5.12 |
HSA-MIR-30b |
1 |
1.05 |
3.83 |
4.48 |
1.00 |
0.64 |
4.54 |
3.51 |
1.00 |
0.99 |
4.91 |
5.33 |
HSA-MIR-31 |
1 |
1.10 |
0.09 |
0.09 |
1.00 |
0.47 |
0.03 |
0.03 |
1.00 |
0.90 |
0.02 |
0.02 |
HSA-MIR-361 |
1 |
0.94 |
2.09 |
2.29 |
1.00 |
0.82 |
4.96 |
5.36 |
1.00 |
0.90 |
4.36 |
5.49 |
HSA-MIR-363 |
1 |
0.81 |
0.29 |
0.23 |
1.00 |
0.83 |
0.15 |
0.12 |
1.00 |
0.92 |
0.01 |
0.01 |
HSA-MIR-720 |
1 |
1.71 |
2.12 |
2.85 |
1.00 |
0.92 |
1.61 |
5.02 |
1.00 |
1.09 |
0.45 |
0.98 |
HSA-MIR-9 |
1 |
0.98 |
0.06 |
0.06 |
1.00 |
0.66 |
0.03 |
0.02 |
1.00 |
1.08 |
0.01 |
0.00 |
HSA-MIR-98 |
1 |
1.11 |
2.60 |
2.63 |
1.00 |
0.93 |
2.17 |
2.86 |
1.00 |
1.08 |
2.31 |
2.28 |
HSA-MIR-99a |
1 |
1.18 |
0.55 |
0.40 |
1.00 |
0.80 |
0.29 |
0.25 |
1.00 |
1.02 |
2.32 |
2.77 |
|
Fold-change Data for miRNAs Common to all Three Platforms |
Table 2: Comparison of the fold-change data for the 26 miRNA assays common to all three platforms. For each platform, miRNA levels are expressed relative to the control sample A. Two-fold or greater increases in miRNA levels relative to sample A are in bold; two-fold or greater decreases in miRNA levels compared to sample A are in italics. |